Efficacy of brief motivational interviewing on smoking cessation at tuberculosis clinics in <scp>T</scp>shwane, <scp>S</scp>outh <scp>A</scp>frica: a randomized controlled trial

Louwagie, Goedele; Okuyemi, Kolawole S.; Ayo‐Yusuf, Olalekan A.

doi:10.1111/add.12671

Cited by 61 publications

(86 citation statements)

References 54 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The introduction of brief tobacco cessation advice for TB patients has been shown to be feasible in a programme setting [35]. A recent randomised controlled trial in Africa also demonstrated that motivational interviewing by lay counsellors doubled sustained smoking abstinence for at least 6 months among TB patients compared with brief advice alone [36]. A randomised controlled trial assessing the effect of smoking cessation on TB treatment outcome under a programme setting would be worth exploring to definitively answer this question.…”

Section: Discussionmentioning

confidence: 99%

Smoking adversely affects treatment response, outcome and relapse in tuberculosis

Leung¹,

Yew

Chan³

et al. 2014

Eur Respir J

141

144

View full text Add to dashboard Cite

The impact of smoking on tuberculosis outcome was evaluated in a territory-wide treatment programme.16 345 consecutive patients undergoing chemotherapy for active tuberculosis in government chest clinics in Hong Kong from 2001 to 2003 were followed up prospectively for 2 years for treatment outcome and subsequently tracked through the territory-wide tuberculosis notification registry for relapse until the end of 2012.Smoking was associated with more extensive lung disease, lung cavitation and positive sputum smear and culture at the baseline. In both current smokers and ex-smokers, sputum smears and cultures were significantly more likely to remain positive after 2 months of treatment. Both categories of smokers were significantly less likely to achieve cure or treatment completion within 2 years. Overall, 16.7% of unsuccessful treatment outcomes were attributable to smoking, with the key contributor being default in current smokers and death in ex-smokers. Among successful treatment completers, there was a clear gradient (hazard ratios of 1.00, 1.33 and 1.63) of relapse risk from never-smokers to ex-smokers and current smokers, with an overall population attributable risk of 19.4% (current smokers: 12.2%; ex-smokers: 7.2%).Smoking adversely affects baseline disease severity, bacteriological response, treatment outcome and relapse in tuberculosis. Smoking cessation likely reduces relapse and secondary transmission. @ERSpublications Smoking adversely affects treatment response in TB. Smoking cessation reduces relapse and secondary transmission.

show abstract

Section: Discussionmentioning

confidence: 99%

Smoking adversely affects treatment response, outcome and relapse in tuberculosis

Leung¹,

Yew

Chan³

et al. 2014

Eur Respir J

141

144

View full text Add to dashboard Cite

show abstract

“…In those that do not, there is often more of a focus on delivery of opportunistic brief advice supporting smoking cessation through alternative existing mechanisms, such as tuberculosis clinics 27, 28. These brief advice approaches vary considerably from the services offered by smoking cessation clinics, largely because they are not designed to follow‐up and track client quit attempts.…”

Section: Methodsmentioning

confidence: 99%

Evaluating clinical stop‐smoking services globally: towards a minimum data set

et al. 2017

View full text Add to dashboard Cite

Background and aimsBehavioural and pharmacological support for smoking cessation improves the chances of success and represents a highly cost‐effective way of preventing chronic disease and premature death. There is a large number of clinical stop‐smoking services throughout the world. These could be connected into a global network to provide data to assess what treatment components are most effective, for what populations and in what settings. To enable this, a minimum data set (MDS) is required to standardize the data captured from smoking cessation services globally.MethodsWe describe some of the key steps involved in developing a global MDS for smoking cessation services and methodologies to be considered for their implementation, including approaches for reaching consensus on data items to include in a MDS and for its robust validation. We use informal approximations of these methods to produce an example global MDS for smoking cessation. Our aim with this is to stimulate further discussion around the development of a global MDS for smoking cessation services.ResultsOur example MDS comprises three sections. The first is a set of data items characterizing treatments offered by a service. The second is a small core set of data items describing clients’ characteristics, engagement with the service and outcomes. The third is an extended set of client data items to be captured in addition to the core data items wherever resources permit.ConclusionsThere would be benefit in establishing a minimum data set (MDS) to standardize data captured for smoking cessation services globally. Once implemented, a formal MDS could provide a basis for meaningful evaluations of different smoking cessation treatments in different populations in a variety of settings across many countries.

show abstract

“…Allocation was concealed. Details of the study setting, recruitment, intervention, baseline and follow-up measurements have been described in detail elsewhere (Louwagie et al, 2014).…”

Section: Designmentioning

confidence: 99%

“…In Pakistan, a behavioural smoking cessation intervention (with or without buproprion therapy) was found to be highly effective in helping patients with suspected TB to quit smoking, compared to usual care (Siddiqi et al, 2013). Moreover, it was found that brief motivational interviewing (MI) delivered by lay health care workers approximately doubled smoking cessation in TB patients in a recent randomised controlled trial in a South African primary health care setting (Louwagie et al, 2014). However, these trials did not identify the predictors of smoking cessation, which may include socio-economic, smokingrelated and psycho-social characteristics.…”

Section: Introductionmentioning

confidence: 99%

“…This study, which is based on secondary analysis of data from a recent South African smoking cessation trial in TB patients (Louwagie et al, 2014), aimed to identify independent predictors of smoking cessation after adjusting for the intervention effect. Identifying predictors of cessation may help to tailor interventions for different target groups in future.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Predictors of tobacco smoking abstinence among tuberculosis patients in South Africa

Louwagie

Ayo‐Yusuf

2015

J Behav Med

Self Cite

View full text Add to dashboard Cite

This study examines predictors of smoking cessation in tuberculosis patients with high HIV co-infection rates in a South African primary care setting. Current smokers were randomly allocated to brief motivational interviewing (n=205) or receipt of a brief message (n=204).Multi-level logistic regression was performed to identify predictors of sustained 3-and 6-month abstinence and 7-day point prevalence abstinence (PPA) at 1 month, with the facility as a random effect. The intervention was ineffective among smokers with high nicotinedependence at 1 month, but was effective for all smokers over longer periods. Higher baseline self-efficacy predicted the 1-month 7-day PPA, but not sustained abstinence. HIVpositive participants' odds of sustained abstinence were about three times higher than those of their HIV-negative counterparts. Results support a more intensive motivational intervention and/or coping skills' training to increase self-efficacy and abstinence rates.Tobacco cessation services can be introduced in tuberculosis services where high HIV coinfection rates occur.

show abstract

Efficacy of brief motivational interviewing on smoking cessation at tuberculosis clinics in Tshwane, South Africa: a randomized controlled trial

Cited by 61 publications

References 54 publications

Smoking adversely affects treatment response, outcome and relapse in tuberculosis

Smoking adversely affects treatment response, outcome and relapse in tuberculosis

Evaluating clinical stop‐smoking services globally: towards a minimum data set

Predictors of tobacco smoking abstinence among tuberculosis patients in South Africa

Contact Info

Product

Resources

About